Correlation Between Solid Biosciences and Century Therapeutics
Can any of the company-specific risk be diversified away by investing in both Solid Biosciences and Century Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Solid Biosciences and Century Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Solid Biosciences LLC and Century Therapeutics, you can compare the effects of market volatilities on Solid Biosciences and Century Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Solid Biosciences with a short position of Century Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Solid Biosciences and Century Therapeutics.
Diversification Opportunities for Solid Biosciences and Century Therapeutics
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Solid and Century is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Solid Biosciences LLC and Century Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Century Therapeutics and Solid Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Solid Biosciences LLC are associated (or correlated) with Century Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Century Therapeutics has no effect on the direction of Solid Biosciences i.e., Solid Biosciences and Century Therapeutics go up and down completely randomly.
Pair Corralation between Solid Biosciences and Century Therapeutics
Given the investment horizon of 90 days Solid Biosciences LLC is expected to generate 1.2 times more return on investment than Century Therapeutics. However, Solid Biosciences is 1.2 times more volatile than Century Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Century Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 751.00 in Solid Biosciences LLC on October 24, 2024 and sell it today you would lose (432.00) from holding Solid Biosciences LLC or give up 57.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Solid Biosciences LLC vs. Century Therapeutics
Performance |
| Timeline |
| Solid Biosciences LLC |
| Century Therapeutics |
Solid Biosciences and Century Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Solid Biosciences and Century Therapeutics
The main advantage of trading using opposite Solid Biosciences and Century Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Solid Biosciences position performs unexpectedly, Century Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Century Therapeutics will offset losses from the drop in Century Therapeutics' long position.| Solid Biosciences vs. Century Therapeutics | Solid Biosciences vs. Edgewise Therapeutics | Solid Biosciences vs. C4 Therapeutics | Solid Biosciences vs. Mineralys Therapeutics, Common |
| Century Therapeutics vs. Edgewise Therapeutics | Century Therapeutics vs. C4 Therapeutics | Century Therapeutics vs. Mineralys Therapeutics, Common | Century Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance |